Ferretts Iron Supplement: Uses, Dosage Context, and What to Know

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Ferretts provides ferrous fumarate, an Fe2+ salt with ~33% elemental iron content — each 150 mg tablet delivers roughly 50 mg elemental iron, a higher concentration per gram than ferrous sulfate or gluconate. Always confirm deficiency through blood testing before starting iron supplementation, since supplementing without a confirmed deficit risks iron overload.

Read more →

Understand what your iron supplements results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

How ferrous fumarate works

Elemental iron content by salt form

The key number in any oral iron supplement is the elemental iron content — how much actual iron the formulation delivers per dose, not the total weight of the iron salt. Different iron salts contain different proportions of elemental iron:

  • Ferrous fumarate (Ferretts) — ~33% elemental iron, so 150 mg fumarate delivers ~50 mg elemental iron
  • Ferrous sulfate — ~20% elemental iron, so 325 mg sulfate delivers ~65 mg elemental iron
  • Ferrous gluconate — ~12% elemental iron, so 300 mg gluconate delivers ~36 mg elemental iron
  • Ferric (trivalent) iron — Varies by formulation and requires reduction to ferrous form before absorption; generally less efficient

Ferrous fumarate's higher elemental iron concentration per gram of salt means each tablet delivers a meaningful iron dose in a smaller physical size than equivalent doses of ferrous sulfate or gluconate — a practical advantage for patients who have difficulty with large tablets or who require precisely controlled dosing.

Absorption mechanism

Ferrous fumarate is an ionic ferrous (Fe2+) iron salt that dissolves in the acidic environment of the stomach. Absorption occurs primarily in the duodenum and upper jejunum through the divalent metal transporter (DMT1) expressed on the luminal surface of enterocytes. The fumarate anion is metabolically neutral and does not contribute to or detract from iron absorption compared with other ferrous salts at equivalent elemental iron doses. Absorption efficiency for ferrous fumarate is comparable to ferrous sulfate in most clinical studies.

Gastrointestinal side effects

As with all ionic ferrous iron supplements, GI side effects are the primary tolerability concern with ferrous fumarate. These include nausea, constipation, dark stools, abdominal cramping, and occasionally diarrhea. The side effects result from free ionic iron interacting with the gastrointestinal mucosa and with the microbiome in the colon. Iron taken on an empty stomach achieves higher absorption but typically causes more GI symptoms; taking it with food reduces absorption by 30-50% but substantially improves tolerability for many patients.

For individuals who cannot tolerate Ferretts or standard ionic iron due to GI effects, sucrosomial iron formulations (such as Sideral Forte) represent an alternative with a different absorption mechanism and a lower GI side effect profile in clinical trial data, though typically at higher cost.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Who is Ferretts used for?

Ferretts is indicated for use in individuals with confirmed iron deficiency, including iron deficiency anemia. Common clinical contexts include:

  • Premenopausal women with heavy menstrual blood loss
  • Pregnant individuals with increased iron requirements
  • Individuals with dietary iron insufficiency (e.g., vegetarian and vegan diets)
  • Individuals with gastrointestinal blood loss (peptic ulcer disease, colorectal disease) — noting that treatment of the underlying cause is essential alongside supplementation
  • Individuals with CKD-related iron deficiency, where Nephro-Tech's Ferretts formulation is sometimes specifically recommended due to the company's specialty focus
  • Individuals who require higher elemental iron doses in fewer tablets

Iron supplementation should be initiated only after laboratory confirmation of iron deficiency. Supplementing iron in individuals with normal or elevated iron stores — including those with undiagnosed hereditary hemochromatosis — can worsen iron overload. The appropriate first step is always iron status testing.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Dosage context

Typical iron repletion doses range from 100 to 200 mg of elemental iron per day in divided doses, though lower doses (40-60 mg elemental iron daily or every other day) are used in some clinical contexts, as research has suggested that lower, less frequent dosing may improve net absorption by reducing hepcidin-mediated inhibition of sequential doses. Optimal dosing for a specific individual depends on the severity of deficiency, the cause, and tolerability — decisions made with a provider based on laboratory results and clinical context.

Because Ferretts tablets provide approximately 50 mg of elemental iron, one to three tablets daily is a typical usage range, but specific dosing guidance must come from the provider managing the deficiency.

Which biomarkers assess iron status before and during supplementation?

  • Ferritin — iron storage; the most sensitive marker for iron depletion
  • Hemoglobin — Oxygen-carrying capacity; reflects established anemia
  • MCV — red cell size; microcytic in iron deficiency anemia
  • TIBC — Iron-binding capacity; elevated in iron deficiency
  • Iron saturation — transferrin saturation; falls in deficiency. Included in iron panel
  • RDW — red cell distribution width; elevated when iron deficiency is actively limiting cell production

Superpower's Baseline Blood Panel includes ferritin, hemoglobin, hematocrit, MCV, RDW, serum iron, TIBC, and iron saturation — the complete foundation for assessing iron status before starting supplementation and confirming response during repletion.

This article is for informational purposes only and does not constitute medical advice. Iron supplementation should be initiated and monitored by a qualified healthcare provider based on laboratory-confirmed iron status. Never supplement iron without first establishing need through blood testing.

Frequently Asked Questions

References

  1. Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD (2023). The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. *Nutrition reviews*, *81*(8), 904-920. https://doi.org/10.1093/nutrit/nuac106
  2. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ (2015). Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. *PloS one*, *10*(2), e0117383. https://doi.org/10.1371/journal.pone.0117383
  3. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. *The Lancet. Haematology*, *4*(11), e524-e533. https://doi.org/10.1016/S2352-3026(17)30182-5
  4. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015). Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. *Blood*, *126*(17), 1981-9. https://doi.org/10.1182/blood-2015-05-642223
  5. Serati M, Torella M (2019). Preventing complications by persistence with iron replacement therapy: a comprehensive literature review. *Current medical research and opinion*, *35*(6), 1065-1072. https://doi.org/10.1080/03007995.2018.1552850

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey